Published online Jun 14, 2019. doi: 10.3748/wjg.v25.i22.2734
Peer-review started: February 6, 2019
First decision: February 26, 2019
Revised: April 29, 2019
Accepted: May 8, 2019
Article in press: May 8, 2019
Published online: June 14, 2019
Processing time: 129 Days and 5.4 Hours
Technological advances and the widespread use of medical imaging have led to an increase in the identification of pancreatic cysts in patients who undergo cross-sectional imaging. Current methods for the diagnosis and risk-stratification of pancreatic cysts are suboptimal, resulting in both unnecessary surgical resection and overlooked cases of neoplasia. Accurate diagnosis is crucial for guiding how a pancreatic cyst is managed, whether with surveillance for low-risk lesions or surgical resection for high-risk lesions. This review aims to summarize the current literature on confocal endomicroscopy and cyst fluid molecular analysis for the evaluation of pancreatic cysts. These recent technologies are promising adjuncts to existing approaches with the potential to improve diagnostic accuracy and ultimately patient outcomes.
Core tip: Current methods for the diagnosis and risk-stratification of pancreatic cysts are suboptimal, resulting in both unnecessary surgical resection and overlooked cases of neoplasia. Novel technologies such as confocal endomicroscopy and cyst fluid molecular analysis are promising adjuncts to the existing standard of care for the management of pancreatic cysts with the potential to improve diagnostic accuracy and ultimately patient outcomes.